Skip to main content
Log in

Arrhythmogenic right ventricular cardiomyopathy

Contribution of cardiac magnetic resonance imaging to the diagnosis

Arrhythmogene rechtsventrikuläre Kardiomyopathie

Beitrag der kardialen Magnetresonanztomographie bei der Diagnosestellung

  • Main topic
  • Published:
Herz Aims and scope Submit manuscript

Abstract

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited disease of the heart muscle, mostly due to genetically defective desmosomal proteins. The disease is characterized by fibrofatty replacement leading to ventricular arrhythmias and sudden death in young people and athletes. There is no single clinical gold standard examination for making a definitive diagnosis. The diagnosis is based on multiple parameters, including: (1) global or regional dysfunction and structural alteration of the right ventricle demonstrated on imaging; (2) tissue characterization by endomyocardial biopsy; (3) repolarization and (4) depolarization electrocardiographic abnormalities; (5) arrhythmias; and (6) family history. The so-called phenocopies must be included in the differential diagnosis, always taking into account that there is no single criterion sufficiently specific for a reliable diagnosis of ARVC. Contrast-enhanced cardiac magnetic resonance imaging (CE-CMR) is not yet included in the revised diagnostic criteria, although this is the only imaging modality able to depict fibrosis as late gadolinium enhancement (LGE) deposition. This review analyzes the role of CMR imaging in the diagnostic work-up of ARVC. The lack of specific diagnostic criteria contributes to the under-recognition of the nonclassic variants of ARVC, i.e., dominant or isolated left ventricular disease.

Zusammenfassung

Die arrhythmogene rechtsventrikuläre Kardiomyopathie (ARVC) ist eine erbliche Herzmuskelerkrankung, bei der – zumeist aufgrund genetisch fehlerhafter desmosomaler Proteine – Herzmuskelzellen durch Fett- und Bindegewebszellen ersetzt werden, was zu ventrikulären Arrhythmien und plötzlichem Herztod bei jungen Menschen und Sportlern führen kann. Es gibt nicht die einzig richtige „Goldstandarduntersuchung“ für die endgültige Diagnosestellung. Letztere setzt sich letztlich aus vielen Parametern zusammen: 1. generelle oder umschriebene Funktionsstörung und Strukturveränderung des rechten Ventrikels (RV), die sich mit bildgebenden Verfahren darstellen lässt, 2. Gewebecharakterisierung durch Endomyokardbiopsie (EMB), 3. Repolarisations- und 4. Depolarisationsstörungen im EKG, 5. Arrhythmien und 6. Familienanamnese. Die Differenzialdiagnose mit sog. „Phänokopien“ ist zwingend, wobei berücksichtigt werden muss, dass es kein „einziges Goldstandardkriterium“ gibt, das spezifisch genug ist, um die Diagnose ARVC zuverlässig zu stellen. Die kontrastverstärkte kardiale Magnetresonanztomographie (CE-CMR) wird bei den revidierten Diagnosekriterien noch nicht berücksichtigt, auch wenn dies das einzige bildgebende Verfahren ist, bei dem sich eine Fibrose als Areal mit Late-Gadolinium-Enhancement (LGE) darstellt. In der vorliegenden Übersicht wird die Rolle der CMR-Bildgebung bei der Diagnosestellung einer ARVC dargestellt. Der Mangel an spezifischen diagnostischen Kriterien trägt dazu bei, dass die nichtklassischen Varianten der ARVC, d. h. dominante oder isolierte linksventrikuläre Formen, unterdiagnostiziert werden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Basso C, Corrado D, Marcus FI et al (2009) Arrhythmogenic right ventricular cardiomyopathy. Lancet 373:1289–1300

    Article  PubMed  Google Scholar 

  2. Thiene G, Nava A, Corrado D et al (1988) Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 318:129–133

    Article  CAS  PubMed  Google Scholar 

  3. Thiene G (2015) The research venture in arrhythmogenic right ventricular cardiomyopathy: a paradigm of translational medicine. Eur Heart J (ehu493)

  4. Basso C, Thiene G, Corrado D et al (1996) Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation 94:983–991

    Article  CAS  PubMed  Google Scholar 

  5. Corrado D, Basso C, Pavei A et al (2006) Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 296:1593–1601

    Article  CAS  PubMed  Google Scholar 

  6. McKenna WJ, Thiene G, Nava A et al (1994) Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 71:215–218

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Marcus FI, McKenna WJ, Sherrill D et al (2010) Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J 3:806–814

    Article  Google Scholar 

  8. Nava A, Bauce B, Basso C et al (2000) Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 36:2226–2233

    Article  CAS  PubMed  Google Scholar 

  9. Quarta G, Husain SI, Flett AS et al (2013) Arrhythmogenic right ventricular cardiomyopathy mimics: role of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 15:16

    Article  PubMed Central  PubMed  Google Scholar 

  10. Sen-Chowdhry S, Syrris P, Ward D et al (2007) Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation 115:1710–1720

    Article  PubMed  Google Scholar 

  11. Basso C, Ronco F, Marcus F et al (2008) Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria. Eur Heart J 29:2760–2771

    Article  PubMed  Google Scholar 

  12. Corrado D, Basso C, Thiene G et al (1997) Spectrum of clinicopathologic manifestations of arrhyth- mogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 30:1512–1520

    Article  CAS  PubMed  Google Scholar 

  13. Basso C, Bauce B, Corrado D, Thiene G (2011) Pathophysiology of arrhythmogenic cardiomyopathy. Nat Rev Cardiol 9:223–233

    Article  PubMed  Google Scholar 

  14. Basso C, Thiene G (2005) Adipositas cordis, fatty infiltration of the right ventricle, and arrhythmogenic right ventricular cardiomyopathy. Just a matter of fat? Cardiovasc Pathol 14:37–41

    Article  PubMed  Google Scholar 

  15. Corrado D, Basso C, Leoni L et al (2005) Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 111:3042–3050

    Article  PubMed  Google Scholar 

  16. Sievers B, Addo M, Franken U, Trappe HJ (2004) Right ventricular wall motion abnormalities found in healthy subjects by cardiovascular magnetic resonance imaging and characterized with a new segmental model. J Cardiovasc Magn Reson 6:601–608

    Article  PubMed  Google Scholar 

  17. Cox MG, Smagt JJ van der, Noorman M et al (2010) Arrhythmogenic right ventricular dysplasia/cardiomyopathy diagnostic task force criteria: impact of new task force criteria. Circ Arrhythm Electrophysiol 3:126–133

    Article  PubMed  Google Scholar 

  18. Protonotarios N, Anastasakis A, Antoniades L et al (2011) Arrhythmogenic right ventricular cardiomyopathy/dysplasia on the basis of the revised diagnostic criteria in affected families with desmosomal mutations. Eur Heart J 32:1097–1104

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Menghetti L, Basso C, Nava A et al (1996) Spin-echo nuclear magnetic resonance for tissue characterisation in arrhythmogenic right ventricular cardiomyopathy. Heart 76:467–470

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Tandri H, Calkins H, Nasir K et al (2003) Magnetic resonance imaging findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 14:476–482

    Article  PubMed  Google Scholar 

  21. Wall EE van der, Kayser HW, Bootsma MM et al (2000) Arrhythmogenic right ventricular dysplasia: MRI findings. Herz 25:356–364

    Article  PubMed  Google Scholar 

  22. Tandri H, Castillo E, Ferrari VA et al (2006) Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol 48:2277–2284

    Article  PubMed  Google Scholar 

  23. Marcus F, Basso C, Gear K, Sorrell VL (2010) Pitfalls in the diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Am J Cardiol 105:1036–1039

    Article  PubMed Central  PubMed  Google Scholar 

  24. Sen-Chowdhry S, Prasad SK, Syrris P et al (2006) Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. J Am Coll Cardiol 48:2132–2140

    Article  PubMed  Google Scholar 

  25. Tandri H, Saranathan M, Rodriguez ER et al (2005) Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 45:98–103

    Article  PubMed  Google Scholar 

  26. Santangeli P, Pieroni M, Dello Russo A et al (2010) Noninvasive diagnosis of electroanatomic abnor- malities in arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol 3:632–638

    Article  PubMed  Google Scholar 

  27. Hunold P, Wieneke H, Bruder O et al (2005) Late enhancement: a new feature in MRI of arrhythmogenic right ventricular cardiomyopathy? J Cardiovasc Magn Reson 7:649–655

    PubMed  Google Scholar 

  28. Dalal D, Tandri H, Judge DP et al (2009) Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy a genetics-magnetic resonance imaging correlation study. J Am Coll Cardiol 53:1289–1299

    Article  PubMed  Google Scholar 

  29. Borgquist R, Haugaa KH, Gilljam T et al (2014) The diagnostic performance of imaging methods in ARVC using the 2010 Task Force criteria. Eur Heart J Cardiovasc Imaging 15:1219–1225

    Article  PubMed  Google Scholar 

  30. Marra MP, Leoni L, Bauce B et al (2012) Imaging study of ventricular scar in arrhythmogenic right ventricular cardiomyopathy: comparison of 3D standard electroanatomical voltage mapping and contrast-enhanced cardiac magnetic resonance. Circ Arrhythm Electrophysiol 5:91–100

    Article  PubMed  Google Scholar 

  31. Lima JA, Judd RM, Bazille A et al (1995) Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation 92:1117–1125

    Article  CAS  PubMed  Google Scholar 

  32. Bauce B, Basso C, Rampazzo A et al (2005) Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur Heart J 26:1666–1675

    Article  CAS  PubMed  Google Scholar 

  33. Pilichou K, Mancini M, Rigato I et al (2014) Nonischemic left ventricular scar: sporadic or familial? Screen the genes, scan the mutation carriers. Circulation 130:e180–e182

    Article  PubMed  Google Scholar 

  34. Yilmaz A, Gdynia HJ, Baccouche H et al (2008) Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach. J Cardiovasc Magn Reson 10:50

    Article  PubMed Central  PubMed  Google Scholar 

  35. Vasaiwala SC, Finn C, Delpriore J et al (2009) Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 20:473–476

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Supported by TRANSAC, University of Padua Strategic Grant CPDA133979/13, Padua, Italy; Registry for Cardio-cerebro-vascular Pathology, Veneto Region, Venice, Italy; Veneto Region Target Research, Venice; PRIN Ministry of Education, University and Research 2010BWY8E9_004, Rome, Italy; Associazione La Stella di Lorenzo ONLUS, Rome, Italy.

Compliance with ethical guidelines

Conflict of interest. M. Perazzolo Marra, S. Rizzo, B. Bauce, M. De Lazzari, K. Pilichou, D. Corrado, G. Thiene, S. Iliceto, and C. Basso state that there are no conflicts of interest. The accompanying manuscript does not include studies on humans or animals.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Basso MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Perazzolo Marra, M., Rizzo, S., Bauce, B. et al. Arrhythmogenic right ventricular cardiomyopathy. Herz 40, 600–606 (2015). https://doi.org/10.1007/s00059-015-4228-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00059-015-4228-0

Keywords

Schlüsselwörter

Navigation